Lee J, Kang S, Koh S
PLoS One. 2025; 20(1):e0317935.
PMID: 39847572
PMC: 11756755.
DOI: 10.1371/journal.pone.0317935.
Brauer S, Schniewind I, Dinter E, Falkenburger B
Acta Neuropathol Commun. 2025; 13(1):13.
PMID: 39833972
PMC: 11749544.
DOI: 10.1186/s40478-024-01923-8.
Bu S, Li X, Pang H, Zhao M, Wang J, Liu Y
J Neurosci. 2025; 45(7).
PMID: 39824632
PMC: 11823334.
DOI: 10.1523/JNEUROSCI.1492-24.2024.
Lin C, Chen H, Lin C, Chang M
Sci Rep. 2025; 15(1):1547.
PMID: 39789334
PMC: 11718304.
DOI: 10.1038/s41598-025-85984-2.
Minibajeva O, Karelis G, Zolovs M, Kenina V
Biomedicines. 2025; 12(12.
PMID: 39767615
PMC: 11673695.
DOI: 10.3390/biomedicines12122709.
Association between GRIN2B polymorphism and Parkinson's disease risk, age at onset, and progression in Southern China.
Cui C, Li H, Bao Y, Han Y, Yu H, Song H
Front Neurol. 2025; 15:1459576.
PMID: 39758784
PMC: 11697588.
DOI: 10.3389/fneur.2024.1459576.
Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson's Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study.
Cavallieri F, Fraternali A, Arnone A, Campanini I, Marti A, Gessani A
J Pers Med. 2024; 14(12).
PMID: 39728063
PMC: 11676129.
DOI: 10.3390/jpm14121150.
Evaluating gait and postural responses to subthalamic stimulation and levodopa: A prospective study using wearable technology.
Cani I, DAscanio I, Baldelli L, Lopane G, Ranciati S, Mantovani P
Eur J Neurol. 2024; 32(1):e16580.
PMID: 39702816
PMC: 11658965.
DOI: 10.1111/ene.16580.
Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson's disease and multiple system atrophy.
Ying C, Li Y, Zhang H, Pang S, Hao S, Hu S
Front Neurosci. 2024; 18:1488820.
PMID: 39687490
PMC: 11647036.
DOI: 10.3389/fnins.2024.1488820.
Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease.
Liu Y, Wang J, Ning F, Wang G, Xie A
Clin Transl Sci. 2024; 17(12):e70111.
PMID: 39676304
PMC: 11647050.
DOI: 10.1111/cts.70111.
Grey matter volume differences across Parkinson's disease motor subtypes in the supplementary motor cortex.
Martin A, Nassif J, Chaluvadi L, Schammel C, Newman-Norlund R, Bollmann S
Neuroimage Clin. 2024; 45:103724.
PMID: 39673940
PMC: 11699459.
DOI: 10.1016/j.nicl.2024.103724.
Different patterns of acute saccadic response to levodopa in de novo Parkinson's disease.
Terravecchia C, Mostile G, Chisari C, Contrafatto F, Salerno A, Donzuso G
J Neurol. 2024; 272(1):24.
PMID: 39666178
DOI: 10.1007/s00415-024-12802-6.
Balance and gait disorders in de novo Parkinson's disease: support for early rehabilitation.
Lindholm B, Hagell P, Odin P, Hansson O, Siennicki-Lantz A, Elmstahl S
J Neurol. 2024; 272(1):11.
PMID: 39666175
PMC: 11638321.
DOI: 10.1007/s00415-024-12804-4.
Efficacy of repetitive transcranial magnetic stimulation combined with peripheral magnetic stimulation on movement symptom and exploration of the optimal population in Parkinson's disease: A randomized controlled trial.
Sun P, Li J, Shen H, Jiang Y, Wang X, Xu T
Medicine (Baltimore). 2024; 103(48):e40689.
PMID: 39612411
PMC: 11608732.
DOI: 10.1097/MD.0000000000040689.
Enhancing MRI radiomics feature reproducibility and classification performance in Parkinson's disease: a harmonization approach to gray-level discretization variability.
Panahi M, Habibi M, Hosseini M
MAGMA. 2024; 38(1):23-35.
PMID: 39607667
DOI: 10.1007/s10334-024-01215-1.
Beta-gamma phase-amplitude coupling of scalp electroencephalography during walking preparation in Parkinson's disease differs depending on the freezing of gait.
Kimoto Y, Tani N, Emura T, Matsuhashi T, Yamamoto T, Fujita Y
Front Hum Neurosci. 2024; 18:1495272.
PMID: 39606789
PMC: 11599176.
DOI: 10.3389/fnhum.2024.1495272.
α-Synuclein Oligomers in Skin Biopsies Predict the Worsening of Cognitive Functions in Parkinson's Disease: A Single-Center Longitudinal Cohort Study.
Contaldi E, Basellini M, Mazzetti S, Calogero A, Colombo A, Cereda V
Int J Mol Sci. 2024; 25(22).
PMID: 39596242
PMC: 11594322.
DOI: 10.3390/ijms252212176.
Driving Abilities and Wearing-Off in Parkinson's Disease: A Driving Simulation Study.
Marano M, Esposito M, Sergi G, Proietti F, Bonura A, Toro S
Brain Sci. 2024; 14(11).
PMID: 39595835
PMC: 11591825.
DOI: 10.3390/brainsci14111072.
Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies.
Kong D, Li C, Ma L, Du L, Jiang N, Zhao X
Signal Transduct Target Ther. 2024; 9(1):320.
PMID: 39551798
PMC: 11570617.
DOI: 10.1038/s41392-024-02020-x.
Occipital hypoperfusion and motor reserve in Parkinson's disease: an early-phase F-FP-CIT PET study.
Yoon Y, Kim S, Jeong S, Park C, Lee H, Lee P
NPJ Parkinsons Dis. 2024; 10(1):221.
PMID: 39551772
PMC: 11570606.
DOI: 10.1038/s41531-024-00834-8.